Riegepant 75MG ODT 8S
Ended Awarded Last action
- Contract number
- SPE2DR26FX0KK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,497
Award facts
- Contract value 100% obligated
- $12,497.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,497.09 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on February 3, 2026, for the supply of Riegepant 75 mg oral disintegrating tablets (8 packs). This is a firm fixed-price, non-set-aside contract with a completion date of February 4, 2026, and performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, serving as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies a wide range of medications and medical products to federal agencies, particularly supporting military and veteran healthcare systems. The company has demonstrated capability to compete successfully on a full and open basis for federal medical procurement contracts, fulfilling orders across multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order represents a routine transaction under the broader pharmaceutical supply framework that ensures the Department of Defense has access to essential medications required by military treatment facilities and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FX0KK?
SPE2DR26FX0KK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26FX0KK worth?
The government has obligated $12,497 on SPE2DR26FX0KK.
Is contract SPE2DR26FX0KK an order under another contract?
Yes. SPE2DR26FX0KK is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FX0KK competed?
The extent of competition for SPE2DR26FX0KK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award